Why BGPT?
logo

Review Papers Claim by Claim

Check each claim against its experiments, reported results, scope, and stated limitations.Know what the science actually supports before you trust the answer.

Press Enter ↡ to start review


     Quick Answer



    Core claim
    The paper reports that CD9 is required for timely cutaneous wound re-epithelialization in mice, and that CD9 loss leads to persistent JNK hyperactivation, elevated MMP-9, excessive degradation of type IV collagen, basement-membrane defects, and delayed epidermal migrationβ€”partly rescuable by JNK inhibition.



     Long Answer



    Paper Review (Visual + Critical): CD9 Is Critical for Cutaneous Wound Healing through JNK Signaling
    Journal of Investigative Dermatology (published ~Sept 2011; DOI: 10.1038/jid.2011.268)
    Figure 1 β€” Time-course summaries explicitly reported
    Below are only the numeric values stated in the provided text (e.g., fold-changes and relative lengths). Everything else remains qualitative in this visualization because exact values weren’t provided.
    Reported value: β€œOn day 7 post wounding, 75% of wounds were closed in wild-type controls, but none in CD9-null mice.”
    Reported values: day 3/5/7 migrating epidermis length in CD9-null is 105% / 71% / 62% of WT.
    Reported values: phospho-JNK levels in CD9-null are 2.7Γ— / 3.4Γ— / 2.4Γ— higher than WT at days 3, 5, 7.
    Mechanistic chain (as stated)
    The authors propose a pathway: CD9 deficiency β†’ sustained epidermal JNK phosphorylation β†’ increased MMP-9 (expression/activity) β†’ increased type IV collagen degradation β†’ defective basement membrane β†’ impaired epidermal migration β†’ delayed re-epithelialization.
    Reported: phospho-JNK vs MMP-9 shows r β‰ˆ 0.86, P < 0.01 (in CD9-null wounds).
    Critical appraisal (skeptical & evidence-weighted)
    Strengths
    • In vivo genetics + multiple readouts: CD9-null mice were compared with littermate WT, and the phenotype is tracked across macroscopic closure, histology (wound/dermal gape), and mechanistic markers (phospho-JNK, MMP-9 activity/expression, type IV collagen deposition/degradation fragments).
    • Pathway perturbation consistent with causality: JNK inhibition (SP600125) reduced phospho-JNK, normalized MMP-9 expression/activity to WT-like levels, reduced collagen degradation, and accelerated wound closure/migration in CD9-null mice.
    Potential limitations / blind spots (what could weaken the inference)
    • Cell-type attribution is mostly correlative by staining: Phospho-JNK and MMP-9 staining are described as β€œprimarily in migrating epidermis,” but the text excerpt doesn’t show single-cell quantification or cell-autonomous genetic control (e.g., epidermis-specific Cd9 deletion). This leaves open contributions from other wound-resident cells (e.g., macrophages/endothelium) beyond epidermal migration.
    • Incomplete rescue implies additional pathways: Even when JNK suppression normalized MMP-9 and reduced collagen degradation, the wound healing kinetics in inhibitor-treated CD9-null mice were not identical to WT controls (e.g., only ~30% closed at day 7 vs 75% in WT, as described in the provided discussion).
    • Specificity of pharmacologic inhibitors: The mechanism assumes SP600125 is acting through JNK to influence MMP-9 and collagen degradation. Without orthogonal genetic JNK perturbation in this specific model (not provided in the excerpt), off-target effects or partial pathway compensation remain a general interpretive concern.
    What would most strongly disprove the paper’s main causal chain?
    • Demonstrate that in CD9-null wounds, phospho-JNK and/or MMP-9 are not elevated (or not causally downstream), yet the healing defect persistsβ€”i.e., phenotypes decoupled from the measured JNK/MMP-9 axis.
    • Show that restoring type IV collagen deposition at the basement membrane rescues migration and closure without affecting MMP-9/JNK activityβ€”contradicting the idea that MMP-9–mediated collagen degradation is the key upstream driver.
    Visual mechanism diagram (text-only, faithfully derived from reported statements)
    CD9 loss β†’ persistent phospho-JNK in migrating epidermis β†’ ↑ MMP-9 (mRNA + protein + enzymatic activity) β†’ ↑ type IV collagen degradation (↑40-kDa fragment; ↓160-kDa deposition at basement membrane) β†’ defective basement membrane β†’ ↓ epidermal migration β†’ delayed re-epithelialization / wound closure.
    Each arrow corresponds to the paper’s reported observations and inhibitor results in the provided full-text/abstract.


    Feedback:    

    Updated: May 01, 2026

     BGPT Paper Review



    Study Novelty

    70%

    The paper connects CD9 (a tetraspanin previously implicated in diverse processes) to a specific in vivo wound-healing mechanism via a CD9→JNK→MMP-9→type IV collagen/basement membrane axis, which is a targeted mechanistic advance for cutaneous wound biology rather than a brand-new pathway discovery.



    Scientific Quality

    70%

    Overall strong qualitative-to-phenotype consistency with in vivo genetic perturbation plus pathway-rescue by JNK inhibition and MMP-9 inhibition (supporting causality). Skeptical caveats: the provided excerpt emphasizes staining localization and pharmacologic inhibition; the excerpt also indicates JNK suppression does not fully restore WT healing, implying additional contributing pathways/cell types not fully resolved in the reported text.



    Study Generality

    60%

    The results are clearly about cutaneous wound re-epithelialization in a mouse model and a specific pathway involving JNK/MMP-9/type IV collagen. Translational or mechanistic generality to other wound types or human physiology is not established in the provided text.



    Study Usefulness

    70%

    Mechanistically useful for generating testable hypotheses linking CD9-controlled signaling to ECM basement-membrane remodeling in epidermal migration; useful as a conceptual framework for further experiments in wound healing and ECM regulation.



    Study Reproducibility

    60%

    Methods are described at a moderate level (mouse model, excisional wound size, inhibitor dosing route/timing, and major assay types). However, the provided excerpt does not specify all procedural details needed for full independent replication (e.g., exact antibody sources/dilutions, exact sample sizes per figure panel beyond partial statements, and complete supplementary methods).



    Explanatory Depth

    70%

    The paper provides a coherent causal chain with multiple intermediate molecular endpoints (phospho-JNK, MMP-9 expression/activity, type IV collagen degradation fragments, basement membrane changes) and functional endpoints (closure/gape, migrating epidermis length). Remaining explanatory gaps include cell-autonomous dissection of epidermal CD9 versus contributions from other CD9-expressing wound compartments.


    🎁 Authors: Collect 172 Free Science Tokens (β‰ˆ $17.2 USD)

    Claim My Author Tokens

    Use for 43 days of free BGPT access (4 tokens = 1 day) or trade/sell (β‰ˆ $17.2 USD)

     Top Data Sources ExportMCP



     Analysis Wizard



    It extracts reported timepoint fold-changes (phospho-JNK, migrating epidermis ratios, closure %) into a dataframe and reproduces Plotly summary charts for mechanistic comparison across days.



     Hypothesis Graveyard



    A simple model where CD9-null delays healing solely by reducing keratinocyte proliferation is unlikely because the excerpt reports no obvious proliferation difference (PCNA staining/Western).


    A model where elevated MMP-9 is independent of JNK is unlikely given the reported co-variation of phospho-JNK and MMP-9 and the normalization of MMP-9 after JNK suppression.

     Science Art


    Paper Review: CD9 Is Critical for Cutaneous Wound Healing through JNK Signaling Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT